Search

Your search keyword '"Gay, Francesca"' showing total 19 results

Search Constraints

Start Over You searched for: Author "Gay, Francesca" Remove constraint Author: "Gay, Francesca" Topic stem cell transplantation Remove constraint Topic: stem cell transplantation
19 results on '"Gay, Francesca"'

Search Results

1. The role of autologous stem-cell transplantation in multiple myeloma in 2021.

2. Oral ixazomib maintenance following autologous stem cell transplantation (TOURMALINE-MM3): a double-blind, randomised, placebo-controlled phase 3 trial.

3. Lenalidomide Maintenance After Autologous Stem-Cell Transplantation in Newly Diagnosed Multiple Myeloma: A Meta-Analysis.

4. Stem Cell Transplantation in Multiple Myeloma.

5. The role of pre-transplant induction regimens and autologous stem cell transplantation in the era of novel targeted agents.

6. Autologous transplantation and maintenance therapy in multiple myeloma.

7. Bortezomib induction, reduced-intensity transplantation, and lenalidomide consolidation-maintenance for myeloma: updated results.

8. Bortezomib as induction before autologous transplantation, followed by lenalidomide as consolidation-maintenance in untreated multiple myeloma patients.

9. First-line treatment of multiple myeloma in elderly patients: the GIMEMA (Gruppo Italiano Malattie EMatologiche dell'Adulto) multiple myeloma working party perspective.

10. Developing and validating a discrete-event simulation model of multiple myeloma disease outcomes and treatment pathways using a national clinical registry.

11. Carfilzomib with cyclophosphamide and dexamethasone or lenalidomide and dexamethasone plus autologous transplantation or carfilzomib plus lenalidomide and dexamethasone, followed by maintenance with carfilzomib plus lenalidomide or lenalidomide alone for patients with newly diagnosed multiple myeloma (FORTE): a randomised, open-label, phase 2 trial.

12. Expert review on soft‐tissue plasmacytomas in multiple myeloma: definition, disease assessment and treatment considerations.

13. Plasma cell leukemia: update on biology and therapy.

14. Chemotherapy plus lenalidomide versus autologous transplantation, followed by lenalidomide plus prednisone versus lenalidomide maintenance, in patients with multiple myeloma: a randomised, multicentre, phase 3 trial.

15. Predicting poor peripheral blood stem cell collection in patients with multiple myeloma receiving pre-transplant induction therapy with novel agents and mobilized with cyclophosphamide plus granulocyte-colony stimulating factor: results from a Gruppo Italiano Malattie EMatologiche dell'Adulto Multiple Myeloma Working Party study

16. Management of older patients with multiple myeloma.

17. Update on Recent Developments for Patients with Newly Diagnosed Multiple Myeloma.

18. Maintenance Therapy with the Oral Proteasome Inhibitor (PI) Ixazomib Significantly Prolongs Progression-Free Survival (PFS) Following Autologous Stem Cell Transplantation (ASCT) in Patients with Newly Diagnosed Multiple Myeloma (NDMM): Phase 3 Tourmaline-MM3 Trial

19. From transplant to novel cellular therapies in multiple myeloma: EMN guidelines and future perspectives

Catalog

Books, media, physical & digital resources